SGAM
IMGN

Smith Group Asset Management’s Immunogen Inc IMGN Stock Holding History

Smith Group Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-92,950
Closed -$1.34M – 437
2015
Q2 		$1.34M Buy
92,950
+1,790
+2% +$19.7K 0.05% 163
2015
Q1 		$816K Sell
91,160
-6,700
-7% -$48.5K 0.03% 182
2014
Q4 		$597K Sell
97,860
-9,410
-9% -$86.1K 0.02% 199
2014
Q3 		$1.14M Buy
+107,270
New +$1.21M 0.04% 172
2014
Q1 		– Sell
-66,236
Closed -$972K – 432
2013
Q4 		$972K Sell
66,236
-453
-0.7% -$6.96K 0.04% 178
2013
Q3 		$1.14M Buy
+66,689
New +$1.17M 0.05% 173

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Smith Group Asset Management's IMGN Position: Q3 2015 in Review

Smith Group Asset Management sold out of Immunogen Inc (IMGN) in Q3 2015, closing a stake of 92,950 shares — an estimated $1.34M sold.

Smith Group Asset Management first reported a position in IMGN in Q3 2013 and held it in 6 quarters. The position peaked at $1.34M in Q2 2015. 151 funds tracked by Wall St. Rank hold IMGN as of Q3 2015.

  • Smith Group Asset Management reported no remaining Immunogen Inc position as of Q3 2015 after selling out during the quarter.
  • Smith Group Asset Management sold 92,950 Immunogen Inc shares in Q3 2015, an estimated $1.34M.
  • Smith Group Asset Management first reported a position in Immunogen Inc in Q3 2013 and held it in 6 quarters.
  • Smith Group Asset Management's Immunogen Inc position peaked at $1.34M in Q2 2015.
  • 151 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2015.

Based on Smith Group Asset Management's 13F filing for Q3 2015, filed 23 Oct 2015.